What’s New

Home What’s New

08

Feb2018

The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update

The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of January 31, 2018: ... Read More

07

Feb2018

PMPRB Form 3 (R&D) Due Date Reminder

This is a reminder to patentees of their filing requirements respecting revenues and development expenditures. These filing requirements are contained ... Read More

01

Feb2018

NEW PDCI Report finds Health Canada significantly overstates benefits & underestimates negative impact of its proposed regulatory amendments

On January 29, 2018, PDCI released a report critically evaluating Health Canada’s plan to change how patented medicine prices ... Read More

30

Jan2018

INESSS Releases Additional Information – Requests for Changes of an Administrative Nature

On January 29, 2018, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers. ... Read More